Taking people in United StatesPhase 2/3
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
Key facts
- Where
- Ann Arbor, Atlanta, Baltimore, Birmingham, Boston, Brooklyn, Chapel Hill, Charleston, Chicago, Cleveland, Durham, Fairborn, Greenville, Hershey, Houston, Kansas City, Lake Success, Lebanon, Louisville, Madison, Milwaukee, New Haven, New Orleans, New York, Norfolk, Philadelphia, Phoenix, Richmond, Rochester, San Francisco, Sandy Springs, St Louis, Troy, Tucson, and Washington D.C., United StatesSee the 35 sites
- Phase
- Phase 2/3
Where in United States
- Ann Arbor, MichiganHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Atlanta, GeorgiaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Baltimore, MarylandHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Birmingham, AlabamaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Boston, MassachusettsHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Brooklyn, New YorkHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Chapel Hill, North CarolinaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Charleston, South CarolinaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Chicago, IllinoisHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Cleveland, OhioHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Durham, North CarolinaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Fairborn, OhioHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Greenville, South CarolinaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Hershey, PennsylvaniaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Houston, TexasHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Kansas City, MissouriHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Lake Success, New YorkHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Lebanon, New HampshireHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Louisville, KentuckyHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Madison, WisconsinHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Milwaukee, WisconsinHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- New Haven, ConnecticutHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- New Orleans, LouisianaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- New YorkHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Norfolk, VirginiaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Philadelphia, PennsylvaniaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Phoenix, ArizonaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Richmond, VirginiaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Rochester, MinnesotaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- San Francisco, CaliforniaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Sandy Springs, GeorgiaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- St Louis, MissouriHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Troy, MichiganHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Tucson, ArizonaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
- Washington D.C., District of ColumbiaHospital not named in the registryContact: Clinical Trial AdministratorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Priovant Therapeutics, Inc.
- Trial code
- NCT06978725EU 2026-526437-25-00
- Record updated
- 3 November 2026
- Original description
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.Read full original descriptionShow less
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Cutaneous Sarcoidosis
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.
Inclusion: Adults subjects; Cutaneous sarcoidosis with characteristic skin biopsy histology; A CSAMI activity score ≥ 10; Weight > 40 kg to < 130 kg, and with a body mass index (BMI) ≤ 45 kg/m2.
Exclusion: History of cancer, with the exception of the following cancers with documentation of complete resection and no evidence of recurrence for ≥ 1 year: basal cell carcinoma, squamous cell carcinoma, or carcinoma in situ of the uterine cervix; High risk of thrombosis or cardiovascular disease; Active or recent infection; High risk of herpes zoster.